Surging Earnings Estimates Signal Upside for Harrow ( HROW ) Stock
Harrow (HROW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stock to Buy for August 15th
ECG, NVT and HROW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 15, 2025.
Wall Street Analysts Think Harrow ( HROW ) Could Surge 53.24%: Read This Before Placing a Bet
The mean of analysts' price targets for Harrow (HROW) points to a 53.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Harrow Unusual Options Activity - Harrow ( NASDAQ:HROW )
High-rolling investors have positioned themselves bullish on Harrow HROW, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW - Harrow ( NASDAQ:HROW )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ( "Harrow" or the "Company" ) HROW. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW - Harrow ( NASDAQ:HROW )
NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ( "Harrow" or the "Company" ) HROW. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Harrow ( HROW ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 - Harrow ( NASDAQ:HROW )
NASHVILLE, Tenn., July 29, 2025 ( GLOBE NEWSWIRE ) -- Harrow HROW, a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the second quarter ended June 30, 2025, on Monday, August 11, 2025, after the market close.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW - Harrow ( NASDAQ:HROW )
NEW YORK, July 28, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ( "Harrow" or the "Company" ) HROW. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Harrow ( HROW ) Stock Jumps 11.4%: Will It Continue to Soar?
Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Harrow ( NASDAQ:HROW ) , Janux Therapeutics ( NASDAQ:JANX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Ladenburg Thalmann analyst Aydin Huseynov initiated coverage on KALA BIO, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW - Harrow ( NASDAQ:HROW )
NEW YORK, July 06, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ( "Harrow" or the "Company" ) HROW. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Are Options Traders Betting on a Big Move in Harrow Stock?
Investors need to pay close attention to HROW stock based on the movements in the options market lately.
William Blair Bullish On Harrow's High-Margin Branded Eye Drug Strategy - Harrow ( NASDAQ:HROW )
BYQLOVI is the first new ophthalmic steroid in its class in over 15 years, with a US launch expected in Q4 2025. William Blair projects peak sales of $355 million for Vevye by 2030 and $300 million for Triesence and Iheezo by 2035. Get access to the leaderboards pointing to tomorrow's biggest ...
Jim Cramer Is 'OK' With Harrow, Recommends This Energy Stock - Devon Energy ( NYSE:DVN ) , Energy Transfer ( NYSE:ET )
When asked about Iron Mountain, Cramer said, "No, better places to be." Get our list of 10 overlooked stocks-including one paying a 9% dividend-before Wall Street catches on. On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Energy Transfer LP ET. "The pipes are a great ...
Harrow ( HROW ) Reports Q1 Loss, Lags Revenue Estimates
Harrow (HROW) delivered earnings and revenue surprises of -2,000% and 19.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
United Therapeutics ( UTHR ) Q1 Earnings and Revenues Top Estimates
United Therapeutics (UTHR) delivered earnings and revenue surprises of 5.41% and 9.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Harrow ( HROW ) Q4 Earnings and Revenues Top Estimates
Harrow (HROW) delivered earnings and revenue surprises of 127.27% and 1.24%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt ( NASDAQ:ADTX ) , FinVolution Gr ( NYSE:FINV )
U.S. stocks traded lower midway through trading, with the S&P 500 falling around 1% on Tuesday. The Dow traded down 0.81% to 41,504.25 while the NASDAQ dipped 1.44% to 17,551.39. The S&P 500 also fell, dropping, 1.04% to 5,616.32. Materials shares fell by just 0.3% on Tuesday.
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday - Diginex ( NASDAQ:DGNX ) , China Liberal Education ( NASDAQ:CLEU )
U.S. stocks were lower, with the Dow Jones index falling around 300 points on Tuesday. Shares of IHS Holding Limited IHS rose sharply during Tuesday's session following fourth-quarter results. IHS Holding reported quarterly earnings of 73 cents per share which beat the analyst consensus estimate ...
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being' - Baidu ( NASDAQ:BIDU ) , Bakkt Hldgs ( NYSE:BKKT )
U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading.
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket - AirNet Technology ( NASDAQ:ANTE ) , AGM Gr Hldgs ( NASDAQ:AGMH )
Shares of Harrow, Inc. HROW rose sharply in pre-market trading after the company reported fourth quarter and year-end 2024 unaudited preliminary financial results and issued 2025 revenue guidance. Harrow shares jumped 23.1% to $28.70 in the pre-market trading session.
Harrow Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Harrow ( NASDAQ:HROW )
Harrow, Inc. HROW will release its fourth-quarter financial results, after the closing bell, on Monday, March 17. Analysts expect the Nashville, Tennessee-based company to report a quarterly loss at 1 cent per share, versus a year-ago loss of 2 cents per share.
Implied Volatility Surging for Harrow ( HROW ) Stock Options
Investors need to pay close attention to Harrow (HROW) stock based on the movements in the options market lately.
Ionis Pharmaceuticals ( IONS ) Reports Q4 Loss, Tops Revenue Estimates
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 41.07% and 65.19%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Harrow ( NASDAQ:HROW ) , HA Sustainable ( NYSE:HASI )
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. William Blair analyst Andy Hsieh initiated coverage on Mersana Therapeutics, Inc.
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Advance Auto Parts ( NYSE:AAP )
U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Thursday. Shares of Advance Auto Parts, Inc. AAP fell sharply in today's pre-market trading after the company reported downbeat quarterly results.
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - DLocal ( NASDAQ:DLO )
Shares of DLocal Limited DLO rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter revenue results. DLocal reported quarterly earnings of 9 cents per share which missed the analyst consensus estimate of 11 cents per share.
Harrow ( HROW ) Reports Q3 Loss, Lags Revenue Estimates
Harrow (HROW) delivered earnings and revenue surprises of -140% and 11.42%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Lyra Therapeutics, Inc. ( LYRA ) Reports Q3 Loss, Lags Revenue Estimates
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of 21.74% and 51.25%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Harrow ( HROW ) Report Negative Earnings Next Week? What You Should Know
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Best Momentum Stocks to Buy for November 6th
HROW, ORLA and SWDBY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 6, 2024.
New Strong Buy Stocks for November 6th
ORLA, SWDBY, SUOPY, HROW and CLPR have been added to the Zacks Rank #1 (Strong Buy) List on November 6, 2024.
Century Therapeutics, Inc. ( IPSC ) Reports Q3 Loss, Tops Revenue Estimates
Century Therapeutics (IPSC) delivered earnings and revenue surprises of 19.57% and 69.74%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Harrow ( HROW ) Upgraded to Strong Buy: What Does It Mean for the Stock?
Harrow (HROW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe Harrow ( HROW ) Could Rally 25.95%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26% in Harrow (HROW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Harrow Unusual Options Activity For October 28 - Harrow ( NASDAQ:HROW )
Deep-pocketed investors have adopted a bearish approach towards Harrow HROW, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day
Chicago, IL - October 25, 2024 - Zacks Equity Research shares GitLab ( GTLB Quick QuoteGTLB - ) as the Bull of the Day and Baidu ( BIDU Quick QuoteBIDU - ) as the Bear of the Day.
Best Momentum Stocks to Buy for October 24th
FOLD, CLPR and HROW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 24, 2024.
New Strong Buy Stocks for October 24th
CLPR, HROW, FOLD, GTLB and TCOM have been added to the Zacks Rank #1 (Strong Buy) List on October 24, 2024.
Nicox and Soleus Sign $16.5 million Royalty and Equity Financing
Press Release ...
Harrow ( HROW ) Surges 8.4%: Is This an Indication of Further Gains?
Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Unpacking the Latest Options Trading Trends in Harrow - Harrow ( NASDAQ:HROW )
Financial giants have made a conspicuous bearish move on Harrow. Our analysis of options history for Harrow HROW revealed 13 unusual trades. Delving into the details, we found 38% of traders were bullish, while 46% showed bearish tendencies.
Harrow ( HROW ) Reports Q2 Loss, Tops Revenue Estimates
Harrow (HROW) delivered earnings and revenue surprises of 48% and 14.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Harrow ( HROW ) Is a Great Choice for 'Trend' Investors, Here's Why
Harrow (HROW) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Top 3 Health Care Stocks That May Crash This Quarter - Eli Lilly and Co ( NYSE:LLY )
As of July 3, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...
Harrow ( HROW ) Soars 12.9%: Is Further Upside Left in the Stock?
Harrow (HROW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday - KB Home ( NYSE:KBH )
U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Thursday. Shares of KB Home KBH rose during Thursday's session as the company posted better-than-expected earnings and sales results for its second quarter on Tuesday.
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday - Sony Group ( NYSE:SONY )
U.S. stocks were higher, with the Dow Jones gaining around 20 points on Tuesday. Shares of Sony Group Corporation SONY rose sharply during Tuesday's session after the company reported better-than-expected quarterly financial results.
VYNE Therapeutics Inc. ( VYNE ) Reports Q1 Loss, Misses Revenue Estimates
VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of 37.50% and 2%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
